From Pharmacy Shelves to Schedule I: The Racist Origins of Cannabis Prohibition

There's a question that hangs over every cannabis dispensary, every legalization bill, every expungement hearing in America: how did a plant that was sold in pharmacies, prescribed by doctors, and required by law for colonial farmers to grow end up classified alongside heroin as one of the most dangerous substances known to science?

The answer isn't complicated. It's just ugly.

Cannabis prohibition in the United States was not built on medical evidence, public health research, or scientific consensus. It was built on racism — specifically, on anti-Mexican immigration sentiment, anti-Black fearmongering, and the political ambitions of a bureaucrat who needed an enemy to justify his department's budget. The science was fabricated. The testimony was fraudulent. And the consequences — mass incarceration, destroyed communities, a medical research blackout lasting decades — are still being felt today.

With the DEA's rescheduling hearing scheduled for June 29, 2026, this history isn't just academic. It's the foundation that the current drug scheduling system was built on, and understanding how rotten that foundation is matters enormously for what comes next.

Ready to find a dispensary near you? Budpedia is the verified directory with real menus, live deals, and city-by-city coverage you can trust.

The Era When Cannabis Was Just Medicine (1619–1910)

Before cannabis was a culture war, it was a crop. And before it was a controlled substance, it was a medicine cabinet staple.

In 1619, the Virginia Assembly passed a law requiring every farm in the colony to grow hemp. Not encouraging. Requiring. Hemp fiber was essential for rope, sails, and textiles, and the colonial economy literally could not function without it. George Washington grew hemp at Mount Vernon. Thomas Jefferson grew it at Monticello. For the first two centuries of American history, cannabis was as unremarkable and economically essential as corn or cotton.

The plant's medicinal chapter began in 1839, when Irish physician William Brooke O'Shaughnessy published his research on cannabis after studying its therapeutic applications in India. He found the plant effective for treating pain, muscle spasms, and nausea, and introduced cannabis preparations to Western medicine. By the 1850s, cannabis tinctures were available in American pharmacies.

This wasn't fringe medicine. Cannabis appeared in the United States Pharmacopeia starting in 1850. Major pharmaceutical companies manufactured cannabis extracts. Doctors prescribed them freely. Your great-great-grandmother might have taken cannabis for headaches without anyone batting an eye — because there was nothing controversial about it.

The 1906 Pure Food and Drug Act included cannabis among substances that had to be properly labeled — not as a restriction, but as a consumer protection measure. Cannabis was still legal, still widely available, still considered ordinary medicine.

For roughly sixty years, cannabis occupied the same regulatory space as aspirin or cough syrup. Then everything changed — and the reasons had nothing to do with medicine.

The Racial Panic That Changed Everything (1910s–1930s)

The Mexican Revolution, which began in 1910, sent waves of immigrants across the southern border into Texas, California, Arizona, and other border states. These immigrants brought with them the practice of smoking cannabis recreationally — a custom that most Anglo Americans were unfamiliar with. The cannabis tinctures in American pharmacies were swallowed, not smoked. The association of smoking cannabis with Mexican immigrants created a cultural fault line that politicians and law enforcement were eager to exploit.

What happened next was a deliberate act of linguistic manipulation. American lawmakers and newspapers began using the word "marihuana" — deliberately employing the Spanish-language term with its distinctive "h" spelling — to describe the drug. This wasn't an accident. The goal was to make cannabis sound foreign, exotic, and threatening. Most Americans who had cannabis tinctures in their medicine cabinets had no idea that "marihuana" was the same plant. The rebranding worked.

In 1913, California became the first state to outlaw cannabis, folding it into a broader package of anti-drug legislation that was explicitly tied to anti-immigrant sentiment. The law targeted "locoweed" and was part of the same nativist political movement that produced anti-Chinese opium laws and other racially motivated drug restrictions.

Between 1914 and 1925, twenty-six states passed laws prohibiting cannabis. The pattern was remarkably consistent: in border states, the laws were framed around anti-Mexican fears. In southern states, they were framed around fears of Black communities. In every case, the actual pharmacological properties of cannabis were almost entirely irrelevant to the legislative debate. What mattered was who was using it and how that could be used to justify surveillance, arrest, and social control.

Harry Anslinger: The Man Who Made It Federal

If racist state-level drug laws were the kindling, Harry Jacob Anslinger was the match.

Anslinger became the head of the newly created Federal Bureau of Narcotics in 1930, and he quickly realized he had a problem: the agency needed a mission that would justify its budget and its existence. Alcohol Prohibition was ending, and the public appetite for aggressive drug enforcement was limited. Anslinger needed a new villain, and he found one in cannabis.

What followed was one of the most cynical and effective propaganda campaigns in American political history. Anslinger cultivated relationships with sympathetic newspaper editors — most notably William Randolph Hearst, whose media empire was happy to publish sensational stories about drug-crazed minorities — and fed them a steady stream of fabricated anecdotes about cannabis causing insanity, violence, and sexual depravity.

The rhetoric was not subtle. Anslinger's public statements and congressional testimony were saturated with racism so explicit that they're difficult to read today. He connected cannabis use to Black and Mexican communities in terms designed to terrify white America, exploiting the same racial anxieties that had driven state-level prohibition for two decades.

Anslinger didn't just use racism as a tactic. It was the entire framework. His case against cannabis wasn't built on medical evidence — the American Medical Association actually opposed his efforts. It was built on the premise that cannabis made racial minorities dangerous and that white America needed to be protected from them.

Reefer Madness and the Tax Act of 1937

While Anslinger worked the halls of Congress, the cultural campaign against cannabis was hitting movie theaters. The 1936 propaganda film "Reefer Madness" depicted cannabis as a gateway to insanity, violence, and suicide. The film was absurd by any scientific standard, but it gave visual form to the fears that newspapers and politicians had been cultivating for years, making the threat of "marihuana" feel immediate and visceral.

In 1937, riding the wave of manufactured hysteria, Congress passed the Marihuana Tax Act. The law didn't technically ban cannabis outright — instead, it imposed a tax and regulatory burden so onerous that legal use became effectively impossible. Physicians who wanted to prescribe cannabis faced extensive paperwork, registration requirements, and the threat of prosecution if they failed to comply perfectly with the new regulations.

The American Medical Association opposed the legislation. Their representative, Dr. William Woodward, testified before Congress that the AMA had not been properly consulted and that the law would interfere with legitimate medical use of the plant. His objections were dismissed. One congressman reportedly asked him why the AMA hadn't submitted its concerns earlier, and Woodward replied that the AMA hadn't realized the legislation was about cannabis — because the congressional committees had consistently referred to it as "marihuana," and the AMA had not connected the unfamiliar term with the familiar medicine.

That exchange captures the entire strategy in miniature. Rename the drug so it sounds foreign. Associate it with despised minority groups. Manufacture public panic. Ignore the medical evidence. Pass the law.

The Escalation: From Tax to Schedule I (1950s–1970)

The Marihuana Tax Act was just the beginning. Over the next three decades, federal cannabis policy became progressively harsher, driven less by any new evidence about the drug's effects and more by the political utility of drug enforcement as a tool of social control.

The 1950s brought mandatory minimum sentences for drug offenses, including cannabis possession. The 1960s counterculture movement — with its association between cannabis, anti-war activism, and racial justice organizing — made the plant a political target of the highest order. Cannabis wasn't just a drug anymore. It was a symbol of everything the political establishment feared: youth rebellion, racial integration, resistance to authority.

In 1970, President Nixon signed the Controlled Substances Act, creating the drug scheduling system that still governs federal drug policy today. Cannabis was placed in Schedule I — the most restrictive category, reserved for substances deemed to have a high potential for abuse, no currently accepted medical use, and a lack of accepted safety for use under medical supervision. This put cannabis in the same legal category as heroin and above cocaine and methamphetamine in terms of regulatory severity.

Nixon actually appointed a commission — the Shafer Commission — to study cannabis and make policy recommendations. The commission concluded that cannabis did not warrant Schedule I classification and recommended decriminalization. Nixon rejected the findings entirely, and the report was shelved.

Years later, one of Nixon's domestic policy advisors, John Ehrlichman, made the political calculus explicit in a statement that has become one of the most frequently cited admissions in drug policy history. He described the administration's drug war as a tool for targeting two groups it considered enemies: the anti-war left and Black Americans. Cannabis enforcement was the mechanism.

The Long Thaw: Medical, Then Recreational (1996–Present)

Prohibition held for over two decades after the Controlled Substances Act before the first cracks appeared. In 1996, California passed Proposition 215, becoming the first state to legalize medical cannabis — driven largely by AIDS activists who had seen firsthand how effective cannabis was at treating nausea and wasting syndrome.

The medical cannabis movement spread slowly through the late 1990s and 2000s, even as the federal government maintained that the drug had no medical value and continued to prosecute patients and providers in legal states. The recreational era began in 2012, when Washington and Colorado became the first states to legalize adult-use cannabis. As of 2024, thirty-eight states have legalized medical cannabis and twenty-four have legalized adult-use.

And yet — cannabis remains a Schedule I substance under federal law. The same classification it received in 1970, built on the same racist propaganda framework that Anslinger constructed in the 1930s, remains technically in effect.

June 29, 2026: The Rescheduling Hearing

That may finally be about to change. The DEA has scheduled a rescheduling hearing for June 29, 2026, which will examine whether cannabis should be moved from Schedule I to Schedule III. This would be the most significant change in federal cannabis policy since the Controlled Substances Act was signed.

Rescheduling to Schedule III would not legalize cannabis, but it would acknowledge that the plant has accepted medical uses — a position now supported by decades of clinical evidence and the lived experience of millions of patients. It would also open the door to expanded federal research, banking access for cannabis businesses, and tax relief under Section 280E.

The hearing will unfold against a backdrop of overwhelming public support for reform — and against the history of how cannabis ended up in Schedule I in the first place. Because the scheduling system was never based on science. It was based on politics, prejudice, and a decades-long campaign of deliberate misinformation.

Why This History Matters Right Now

There's a tendency in cannabis policy discussions to treat prohibition as a well-intentioned mistake — a policy that seemed reasonable at the time but turned out to be wrong. That framing is generous to the point of dishonesty.

Cannabis prohibition was not a mistake. It was a strategy. It was designed to criminalize specific communities, and it worked exactly as intended. The War on Drugs that followed was not a public health campaign that went awry — it was a law enforcement campaign that achieved precisely the outcomes its architects sought. Mass incarceration. Destroyed communities. A permanent underclass of people with criminal records who could be legally denied housing, employment, and voting rights.

As we approach the June 29 hearing, the decisions being made right now about rescheduling, social equity, expungement, and reinvestment are a direct response to the policies that Harry Anslinger set in motion. You can't understand where cannabis policy needs to go without understanding where it came from.

And where it came from is racism. Full stop.